Novartis Builds on PEI's Strengths
Location Canada 2009
According to Novartis Canada CEO Grant Roberts, "By expanding our facilities, we are supporting aquaculture through continued in-depth study of health solutions for the challenges that face both currently cultured and emerging species of fish." Roberts sees a number of advantages to the company's investments in Prince Edward Island: "PEI has quality marine resources and top research institutes that make it attractive for a company like Novartis to maintain one of our five global research and development centers here," he concludes. "We look forward to continuing the great partnerships in place here."
Project Announcements
AstraZeneca Expands Mississauga, Ontario, Canada, Research-Development Campus
02/28/2023
Magna Expands Ontario, Canada, Operations
02/16/2023
Pfizer Expands Kalamazoo, Michigan, Operations
12/14/2022
Siwin Foods Expands Edmonton, Alberta, Production Plant
12/14/2022
The Cultivated B Plans Burlington, Ontario, Bioengineering Facility-Innovation Hub
10/31/2022
Southland Trailer Plans Alberta, Canada, Manufacturing Plant
10/08/2022
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
19th Annual Consultants Survey: Clients Challenged by Tight Labor Market, Energy Availability
Q1 2023
-
The Top Investment Location Prospects for Aerospace Manufacturing
Q1 2023
-
2022 Top States for Doing Business Provide an Environment for Business Growth
Q3 2022
-
36th Annual Corporate Survey: Executives Focus on Labor, Energy, Shipping Costs
Q1 2022
-
How Are Economic Developers Partnering to Solve Workforce Challenges?
Q1 2023
-
Strategies to Overcome Intensifying Industrial Real Estate Challenges
Q1 2023